MC4R and hyperinsulinemic hypoglycemia, familial, 4: Targeted agonism of the MC4R with setmelanotide showed ~10% body weight loss in patients with POMC deficiency and LEPR deficiency (14), and there are case reports showing weight loss after GLP-1 therapy in individuals with pathogenic variants of MC4R (15–17).